Get started
Live feed
·
PRReleasevia Quantisnow
Kintara Therapeutics Inc. logo

Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences

ByQuantisnow·Wall Street's wire, on your screen.
KTRAKintara Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KTRA (Kintara Therapeutics Inc.) and more on Quantisnow.